IgG, IgM, and Nonstructural Protein 1 Response Profiles after Receipt of Tetravalent Dengue Vaccine TAK-003 in a Phase 2 Randomized Controlled Trial
The American Journal of Tropical Medicine and Hygiene · 2024
DOI: 10.4269/ajtmh.23-0549 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2024. Verfasst von Jenny G Low und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Singapore General Hospital, Singapore. Hauptthemen laut MEDLINE: Dengue Vaccines, Immunoglobulin M, Immunoglobulin G, Dengue. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The profiles of vaccine-induced dengue antibodies may differ from those produced following natural infection and could potentially interfere with the interpretation of diagnostic tests. We assessed anti-dengue IgG and IgM antibodies, and nonstructural protein 1 antigen profiles in the serum of adults who received a single dose of the tetravalent dengue vaccine TAK-003 as either an initially developed high-dose formulation or the standard approved formulation in a phase 2 study in Singapore (#NCT02425098). Immunoglobulin G and IgM profiles during the first 30 days postvaccination varied by baseline serostatus (microneutralization assay). Nonstructural protein 1 antigen was not detected in the serum of any participants. Vaccine-induced IgG and IgM antibodies can affect serological confirmation of subsequent dengue infection in vaccinees. These results highlight the limitations of using serological tests for dengue diagnosis, particularly in a postvaccination setting, and emphasize the need for more sensitive antigen- and molecular-based testing for accurate dengue diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Singapore General Hospital, Singapore.
- Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
- Changi General Hospital, Singapore.
- National Centre for Infectious Diseases, Singapore.
- Saw Swee Hock School of Public Health, National University of Singapore, Singapore.
- SingHealth Duke-NUS Global Health Institute, Duke-NUS Medical School, Singapore.
Zitieren
APA
Low, J. G., Oh, H. M., Leo, Y. S., Kalimuddin, S., Wijaya, L., Pang, J., Lee, T. H., Moss, K. J., Brose, M., & Tricou, V. (2024). IgG, IgM, and Nonstructural Protein 1 Response Profiles after Receipt of Tetravalent Dengue Vaccine TAK-003 in a Phase 2 Randomized Controlled Trial. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.23-0549
Vancouver
Low JG, Oh HM, Leo YS, Kalimuddin S, Wijaya L, Pang J, et al. IgG, IgM, and Nonstructural Protein 1 Response Profiles after Receipt of Tetravalent Dengue Vaccine TAK-003 in a Phase 2 Randomized Controlled Trial. The American Journal of Tropical Medicine and Hygiene. 2024. doi:10.4269/ajtmh.23-0549
BibTeX
@article{Low2024,
author = {Low, Jenny G and Oh, Helen M and Leo, Yee-Sin and Kalimuddin, Shirin and Wijaya, Limin and Pang, Junxiong and Lee, Tau Hong and Moss, Kelley J and Brose, Manja and Tricou, Vianney},
title = {IgG, IgM, and Nonstructural Protein 1 Response Profiles after Receipt of Tetravalent Dengue Vaccine TAK-003 in a Phase 2 Randomized Controlled Trial},
journal = {The American Journal of Tropical Medicine and Hygiene},
year = {2024},
doi = {10.4269/ajtmh.23-0549}
}
EUVIMED